Skip to content

DFTX - Definium Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchD

Definium Therapeutics, Inc.

DFTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

D

DFTXDefinium Therapeutics, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $49.70
52-wk low: $8.70
Prev close: $31.12
Mkt cap: $6.16B
Beta: 2.26
P/B: 6.8x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$1.2B

CI
Citadel
Ken Griffin · Q2 2026 13F
$79.4M
position
MW
Marshall Wace

Earnings

Reported Jul 30, 2026

Earnings came in $0.89 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $6.2B

Valuation

P/B6.75

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: DFTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $6.16B
Beta: 2.26

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-64.1%

Q2 2026 13F

$61.1M

position

TS

Two Sigma

Q2 2026 13F

$43.4M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for DFTX

No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.44-$0.89

-$0.55 expected

Next report

What the street expects next

EPS expected

-$0.52

-$0.66 to -$0.39

Revenue expected

$0.00

15 analysts

Last 30 days

2up1down

Analysts raising estimates

Estimate drift

+0.03

Change in 30 days

-64.1%

ROA-20.6%

Growth

Beta2.26